Exelixis Inc Inventory, Noncurrent
Exelixis Inc (EXEL) had Inventory, Noncurrent of $379.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2017-11-01
- 2017-09-30: Inventory, Noncurrent $379.00K.
- 2017-06-30: Inventory, Noncurrent $143.00K.
- 2017-03-31: Inventory, Noncurrent $624.00K.
- 2016-12-31: Inventory, Noncurrent $606.00K.
| Period end | Inventory, Noncurrent |
|---|---|
| 2017-09-30 | $379.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $143.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $624.00K 10-Q · filed 2017-05-01 |
| 2016-12-31 | $606.00K 10-Q · filed 2017-11-01 |
| 2016-09-30 | $720.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.16M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $1.01M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $1.25M 10-K · filed 2017-02-27 |
| 2015-09-30 | $1.89M 10-Q · filed 2015-11-10 |
| 2014-12-31 | $2.14M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |